Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease

By Chan Edmond Y.W.  

Human Molecular Genetics, Vol. 11, Iss. 17, 2002-06 ,pp. : 1939-1951

Oxford University Press

Access to resources Recommend Favorite

Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease

By Wang Chuan-En   Tydlacka Suzanne   Orr Adam L.   Yang Shang-Hsun   Graham Rona K.   Hayden Michael R.   Li Shihua   Chan Anthony W.S.   Li Xiao-Jiang  

Human Molecular Genetics, Vol. 17, Iss. 17, 2008-09 ,pp. : 2738-2751

Oxford University Press

Access to resources Recommend Favorite

Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin

By Wang Hongmin   Lim Precious J.   Vogel Bruce E.   Monteiro Mervyn J.  

Human Molecular Genetics, Vol. 15, Iss. 6, 2006-03 ,pp. : 1025-1041

Oxford University Press

Access to resources Recommend Favorite

Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models

By Tauffenberger Arnaud   Chitramuthu Babykumari P.   Bateman Andrew   Bennett Hugh PJ.   Parker J. Alex  

Human Molecular Genetics, Vol. 22, Iss. 4, 2013-02 ,pp. : 782-794

Oxford University Press

Access to resources Recommend Favorite

α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease

By Tomás-Zapico Cristina   Díez-Zaera María   Ferrer Isidre   Gómez-Ramos Pilar   Morán María A.   Miras-Portugal M. Teresa   Díaz-Hernández Miguel   Lucas José J.  

Human Molecular Genetics, Vol. 21, Iss. 3, 2012-02 ,pp. : 495-510

Oxford University Press

Access to resources Recommend Favorite